Evidence map›Paper›PMID 41493755›Full record

ArticleInternational journal of clinical pharmacy2026

Advancing pharmacist involvement in surgical prehabilitation: a call to action for global pharmacy practice.

Yong Wang, Junxiong Lu, Junyan Wu, Ruolun Wang, Li Wei, Yilei Li, Yingtong Zeng, Xiaoyan Li, Jisheng Chen, Bo Ji and 12 more

Abstract read
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Yong WangGuangdong Pharmaceutical Association, Guangzhou, 510080, Guangdong, China.
Junxiong LuThe Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong, China.
Junyan WuSun Yat-Sen Memorial Hospital, Sun Yat-Sen University, Guangzhou, 510120, Guangdong, China.
Ruolun WangThe Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, 510260, Guangdong, China.
Li WeiThe First Affiliate Hospital of Guangzhou Medical University, Guangzhou, 510163, Guangdong, China.
Yilei LiNanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Yingtong ZengGuangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Guangzhou, 510080, Guangdong, China.
Xiaoyan LiThe Sixth Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510655, Guangdong, China.
Jisheng ChenThe First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Bo JiGeneral Hospital of Southern Theater Command of PLA, Guangzhou, 510010, Guangdong, China.
Tao LiuSun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.
Hongwei WuThe First Affiliated Hospital/School of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou, 510080, Guangdong, China.
Jinghao WangThe First Affiliated Hospital, Jinan University, Guangzhou, 510630, Guangdong, China.
Haiyan MaiThe Third Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510630, Guangdong, China.
Ping ZhengNanfang Hospital, Southern Medical University, Guangzhou, 510515, Guangdong, China.
Shanshan YuZhujiang Hospital, Southern Medical University, Guangzhou, 510282, Guangdong, China.
Pan ChenThe First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510080, Guangdong, China.
Chen YangGeneral Hospital of Southern Theater Command of PLA, Guangzhou, 510010, Guangdong, China.
Pengjiu YuThe First Affiliate Hospital of Guangzhou Medical University, Guangzhou, 510163, Guangdong, China.
Xiaolan MoGuangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, 510623, Guangdong, China.
Yanfang ChenGuangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, 510440, Guangdong, China.
Zhihua ZhengGuangdong Pharmaceutical Association, Guangzhou, 510080, Guangdong, China. snownotrace@126.com.ORCID http://orcid.org/0000-0001-9312-5846

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prehabilitation has emerged as a proactive, multimodal strategy in perioperative care, aiming to enhance functional capacity and resilience before surgery through medical optimization, exercise, nutrition, and psychological support. Despite their multidisciplinary nature, pharmacists are underutilized in this evolving field. Pharmacists are uniquely positioned to advance prehabilitation by applying Medication Therapy Management (MTM) and Collaborative Drug Therapy Management (CDTM) models to identify medication-related risks, manage comorbidities, and optimize perioperative outcomes. China's experience provides a compelling demonstration of this potential. Since 2015, Zhihua Zheng and colleagues at the Guangdong Pharmaceutical Association have pioneered surgical pharmacy, integrating MTM into pharmacist-managed clinics and employing CDTM frameworks to extend pharmacists' clinical authority in China. These innovations empower pharmacists to perform key prehabilitation functions, such as optimizing complex medication regimens, mitigating polypharmacy, stabilizing cardiovascular and metabolic parameters, managing nutrition and anemia, and supporting pain control. Internationally, prehabilitation has gained traction through initiatives such as Enhanced Recovery After Surgery programs and perioperative surgical home models. However, the pharmacist's contribution remains insufficiently defined. This commentary aims to highlight strategic opportunities for strengthening pharmacist involvement in prehabilitation rather than prescribing detailed operational protocols. Integrating MTM and CDTM conceptually within prehabilitation teams offers a scalable, evidence-informed direction that can guide health systems to enhance perioperative safety and readiness. Pharmacist-led interventions not only reduce medication errors and adverse events but also complement the work of surgeons, anesthesiologists, nutritionists, and rehabilitation specialists. Global collaboration is essential for standardizing competencies, developing training frameworks, and strengthening the evidence for pharmacist-led prehabilitation. The International Pharmaceutical Federation (FIP), the American Society of Health-System Pharmacists (ASHP), and the European Society of Clinical Pharmacy can catalyze this progress by promoting education, guidelines, and policy integration. By embedding MTM/CDTM into surgical prehabilitation, health systems can empower pharmacists to enhance patient safety, improve surgical outcomes, and advance the global standards of perioperative care.

Indexed as

Medication Therapy ManagementPerioperative CarePharmaceutical ServicesPharmacistsPreoperative CareProfessional RoleHumansCollaborative drug therapy managementMedication therapy managementPerioperative carePharmacistsPolypharmacyPrehabilitationSurgical pharmacy

Identifiers

PMID41493755
PMCPMC12992372

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.